Clinical Trial Update: Utility of Brexanolone to Target Stress-induced Alcohol Use Among Men and Women With Posttraumatic Stress Disorder [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating brexanolone for stress-induced alcohol use in adults with PTSD; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder
• Post-traumatic Stress Disorder

Drugs mentioned

• brexanolone (Zulresso) (brexanolone)

Snippet

Sponsor: Yale University | Conditions: PTSD, Alcohol Use Disorder | Phase 1 | Status: ACTIVE_NOT_RECRUITING